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SUMMARY
To examine the relationship between lymphocyte phenotypes and states of activation in patients with
Bancroftian filariasis, dual colour flow cytometry and concurrent in vitro cell culture were performed
on normal individuals (NV: n = 15), and on patients with either asymptomatic microfilaraemia (MF;
n = 12) or elephantiasis (CP: n = 11). In contrast to findings by others in a population with Brugian
filariasis, the percentages of total B lymphocytes (CD19). T lymphocytes (CD3), helper inducer T
lymphocytes (CD4), and suppressor/cytotoxic T lymphocytes (CD8) in both patient groups were
found to be within the range defined by clinically normal individuals. Furthermore. there were no
differences among the groups in the expression of the IL-2 receptor (CD25) on T cells. There was,
however, a significantly greater proportion (P < 0.01) of ‘activated’ cytotoxic suppressor lympho-
cytes (defined by co-expression of CDS and HLA-DR) in patients with elephantiasis (16.4 ± 5.6%)
than in the MF (8.9 ± 2.6%) or NV (8.3 ± 2.9%) groups. Further, when the expression of this
activation antigen was examined in parallel with in vitro mitogen responsiveness, an inverse
correlation between the percentage of CD8+ HLA-DR+ lymphocytes and pokeweed mitogen-
induced proliferation was seen (r= –0.54; P < 0.001). These data provide further definition of the
immunoregulatory abnormalities seen in human filarial infections and suggest that activated CD8+ T
lymphocytes may be involved in the pathogenesis of the chronic obstructed lymphatic form of this
disease.
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INTRODUCTION vivo antibody production in response to the parasite are all
The lymphatic filariases are chronic infections of humans caused
by the nematode parasites Wuchereria bancrofti, Brugia malayi,
and Brugia timori. A striking feature of lymphatic filariasis is the
variety of clinical manifestations seen among those living within
the same endemic environment (Ottesen, 1980); these include
chronic lymphatic pathology manifesting as elephantiasis (CP),
recurrent episodes of filarial fevers or adenolymphangitis (FF),
tropical pulmonary eosinophilia (TPE), and a clinically asymp-
tomatic condition characterized by persistent microfilaraemia
(MF).
These differing clinical manifestations of infection have been
found to be associated with differences in immune responsive-
ness to parasite antigens (Ottesen, 1984). For example, lympho-
cyte proliferation, lymphokine generation and in vitro and in
much greater in patients with CP than in those with MF
(Ottesen, Weller & Heck. 1977; Ottesen et al., 1982; Piessens et
al., 1980a; Hussain et al. 1981; Nutman, Kumaraswami &
Ottesen, 1987a). Though these findings point directly to an
immunological abnormality which is parasite specific, the exact
role of immune processes in the pathogenesis of obstructive
filariasis is still uncertain. Indeed, many features of the immune
alterations themselves remain undefined; for example, the
specific cell types involved in the immunologic defect and the
possible differences in cell subset activation between those with
asymptomatic infection and those with chronic disease. To
address these issues directly, we have utilized multiparameter
flow cytometry (FACS) analysis to provide a highly sensitive
and specific approach to phenotypic analysis of the human
mononuclear cell subsets. Further, in order to examine the
Correspondence: Dr E. Ottesen, Building 4, Room 126, Laboratory relation between disease expression and the state of cellular
of Parasitic Diseases, National Institutes of Health, Bethesda, MD ‘activation’ we have focussed on the expression of HLA-DR and
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Table 1. South Indian patient population (Wuchereria bancrofti) Analysis of lymphocyte subsets
Diagnosis
Age* Sex
No. (years) (M/F) MF/ml*
Filariasis
Lymphatic obstruction (CP) 11 45 3/8 0
(37-65)             
Asymptomatic microfilaraemia (MF) 12 27 11/1 430
(19-47) (4-1350)
Normal controls 15 34 9/6 0
(21-48)
l Median (and range).
patients with filariasis. Immune responsiveness to mitogens was
evaluated concurrently in an effort to identify any general
functional abnormality associated with the altered lymphocyte,
phenotypes observed.
The choice of antibodies and the method for antibody staining
of human lymphocytes which permit storage of these cells for
two or more weeks before assay have previously been described
(Lal, Edison & Chused, 1988). Briefly, one million cells were
stained with a combination of saturating amounts of directly
labelled MoAbs to human lymphocyte differentiation antigens
for 30 min at 4°C. After three washes in phosphate buffered
saline, 400 µ1 of 1% freshly made paraformaldehyde were added
to the cell pellet and in&bated for 30 min at 4°C. Four millilitres
of cold Hank’s balanced salt solution supplemented with 0.1%
bovine serum albumin (BSA) and 3 mM sodium azide (HBSS)
were added to each tube, and the tubes were centrifuged at 400 g
for 7 min at 4°C. After two more washes, the final cell pellet was
resuspended in 0.5 ml of cold HBSS with 1% BSA. These
suspensions were kept at 4°C in the dark and flown to the NIH
within 12 days, where flow cytometric analysis was performed.
Flow cytometry (FACS) analysis
MATERIALS AND METHODS
Study population
Thirty-eight adult volunteers, living in the area of Madras.
India, where filariasis with periodic W. bancrofti is endemic.
were studied (Table 1). Eleven patients had CP with no
circulating microfilariae, 12 had a variable number of circulat-
ing microfilariae (MF) with no symptoms of disease, and 15
were normal volunteers with no parasitological or clinical
evidence of infection. Eight of the 12 MF patients had received a
single dose of the anti-filarial drug ivermectin one year prior to
this study. All the blood samples were collected and processed in
Madras, India.
Monoclonal antibodies
The following monoclonal antibodies (MoAb) were used in this
study: Leu4 (anti-CD3, pan T-cell antigen), Leu2a [anti-CD8,
suppressor/cytotoxic T-cell antigen (Engleman et al., 1981)].
Leu3a [anti-CD4, helper/inducer T-cell antigen (Engleman et
al.. 1981)], Leu12 [anti-CD19, B cell associated antigen (Clark.
Shu & Ledbetter, 1985)], L243 [anti-HLA-DR (Reinherz et al..
1979)], and 2A3 (anti-CD25, IL-2R (Uchiyama, Broder &
Waldman, 1981)]. All but L243 were IgGl; L243 was an IgG2a.
Irrelevant isotype-matched antibodies (mouse IgGl and mouse
IgG2a) were included as controls for non-specific immunofluor-
escence. All the MoAbs were directly conjugated with either
fluorescein isothiocyanate (FITC) or phycoerythrin (PE) and
were purchased from Becton Dickinson Immunocytometry
(Mountain View, CA).
The cells were analysed by a Coulter Epics V flow cytometer.
The data were collected per 10 000 lymphocytes for each tube,
and parameter data (abscissa, FITC fluorescence and ordinate,
PE fluorescence) were displayed as contour maps indicating
increasing number of cells in a defined area of display. In every
case, the percentage of cells showing positive staining was
calculated by first acquiring results for an isotype matched non-
binding control antibody coupled to the appropriate fluoroch-
come (FITC or PE). The lower channel was then set to a
threshold which indicated 2% of the cells showing fluorescence
above the threshold. Results for experimental samples were then
collected and the percentage of cells showing positive fluores-
cence determined as the number of cells exceeding the set
threshold. divided by the total number of cells analysed in the
cytogram gate, multiplied by 100. For double stained popula-
tions, the percent was calculated by dividing the number of cells
stained by a particular monoclonal antibody by that of the total
number of cells gated. Each of the monoclonals to lymphocyte
subsets was used in at least three independent combinations for
each person, and the mean of these readings (always extremely
close) was used to enumerate the percentage of each phenotype.
Lymphocyte function
Isolation of peripheral blood mononuclear cells (PBMC)
The collected heparinized blood was diluted with an equal
volume of RPMI-1640 (M. A. Bioproducts, Walkersville, MD).
and lymphocytes were obtained by sedimentation on a Ficoll-
Diatrizoategradient (LSM, Litton Bionetics, Rockville, MD) at
400 g for 40 min at room temperature by standard procedures
(Boyum, 1968). The cells at the interface were collected, washed
three times in RPMI-1640 at 400 g for 10 min at 4° C. The cell
concentration was adjusted after trypan blue enumeration.
Lymphocyte function was determined using blastogenic re-
sponses to the following stimuli: phytohaemagglutinin (PHA;
Wellcome Diagnostics, Dartford, England): concanavalin A
(ConA: Ey Labs, San Mateo, CA), pokeweed mitogen (PWM;
Gibco Laboratories, Grand Island, NY). Lymphocytes were
adjusted to 1 x 106/ml in RPMI 1640 containing 10% human AB
serum and cultured in 0.2 ml in 96-well, round-bottomed
microtitre trays with or without PHA (2 and 1 µg/ml), ConA (20
and 10 µg/ml), and PWM (1/40, 1/80, and 1/160 dilution).
Blastogenesis was determined by measuring the levels of DNA
synthesis upon addition of 1 µCi of [3H]thymidine (New
England Nuclear, Boston, MA) to each well 18 h prior to
termination of the culture. The labelled cells were harvested with
a multiple sample harvester on glass fibre filters and were
counted by liquid scintillation spectroscopy. Data are expressed
as the stimulation index (SI) obtained by dividing the ct/min
(mean of triplicate cultures) of the mitogen-stimulated cultures
by the mean ct/min of the control cultures.
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Table 2. Cell populations in filariasis patients and normal controls
according to monoclonal antibody binding*
Antigen Normal Microfilaraemic Elephantiasis
cluster (n= 15) (n= 12) ( n = l l )
CD3 79.3 ± 6.5 79.9 ± 5.0  72.9 ± 8.07
CD4 39.68 ± 7.9 39.9 ± 6.2 36.66 ± 9.3
CD8 29.63 ± 3.9 33.01 ± 5.2 31.3 ± 7.9
CD4/CD8 1.38 ± 0.48 1.26 ± 0.36 1.29 ± 0.64
CD19 13.72 ± 4.6 10.34 ± 3.78 11.22 ± 5.7
CD25 1.8 ± 0.66 1.86 ± 0.36 1.98 ± 0.92
HLA-DR 17.09 ± 5.2 14.56 ± 4.26 20.61 ± 7.34
C D 3 +  DR + 16.09 ± 4.2 14.40 ± 4.6 25.10 ± 10.45†
CD19+  DR+ 79.24 ± 13.2 81.55 ± 7.64 85.56 ± 9.4
*Values are expressed as mean ± s.d.
† P < 0.01, when compared with normal or MF.
Statistical evaluation
The Student’s t-test and the Spearman rank correlation coeffi-
cient were used for statistical evaluation as noted.
RESULTS
Lymphocyte subsets in filariasis
Lymphocyte subsets in all subjects were enumerated by one- and
two-colour FACS analysis using multiple MoAbs. The percent-
age of total B lymphocytes (CD19), T lymphocytes (CD3),
helper/inducer T lymphocytes (CD4), or suppressor/cytotoxic T
lymphocytes (GD8) in either clinical group did not differ
significantly from those of the normal subjects (Table 2). The
total percentages of cells bearing surface IL-2R (CD25) or
HLA-DR were also within the normal range; however, among
the lymphocyte subpopulations examined. CD3 + T cells bearing
the HLA-DR antigen were significantly more frequent in the
patients with CP, being increased almost two-fold in compari-
son with either the normal controls or those with MF (Table 2).
Total B cell populations bearing the HLA-DR antigen were
within the normal range for all groups.
Distribution of HLA-DR antigen on T lymphocytes
To investigate further the T lymphocyte subset bearing the
HLA-DR antigen, two-colour FACS analysis was performed
using a PE-labelled antibody to CD4 or CD8 and a fluorescein-
labelled antibody to HLA-DR. As seen in a representative
analysis, an abnormal population of CD8+ lymphocytes bear-
ing the HLA-DR antigen was identified in patients with CP (Fig.
1 b) when compared to normals (Fig. la) or patients with MF
(data not shown). Additionally, there was only a slight increase
(statistically not significant) in the HLA-DR+ CD4+ T lympho-
cytes (Fig. 1) in the same patients.
According to the thresholds defined by analysis of unlabelled
cells, an increase in the percentage of HLA-DR+ CD8+
lymphocytes was evident in 7 of the 11 patients with CP (Fig. 2a)
when compared to normal individuals (shaded area) or those
with MF in whom only 2/12 had even a modest increase. Indeed,
the mean percent of CD8+ HLA-DR+ lymphocytes in patients
with CP was 16.4 ± 8.6% vs. 8.9 ± 2.6% in those with MF
(P<0.01). There was only a slight increase (statistically not
significant) in the mean percentage of HLA-DR+ CD4+
lymphocytes in CP patients (Fig. 2b).
HLA-DR
Fig. 1. Activated CD8+ T suppressor/cytotoxic lymphocytes in a patient
with elephantiasis. Peripheral blood mononuclear cells from a. normal
subject (a and c) and a patient with elephantiasis (b and d) stained with
monoclonal antibodies to both HLA-DR and either CD8 (a and b) or
CD4 (c and d) before flow cytometry. A population of doubly labelled
HLA-DR+ CD8+ cells (12.41%) is apparent in the patient (panel b);
HLA-DR+ CD4 cells (2.96%) in the same patient (d) were not
statistically different from the normal control.
Fig. 2. Activated suppressor T lymphocytes (HLA-DR+ CD8+) (a) and
activated helper T lymphocytes (HLA-DR+ CD4+)(b) in patients with
elephantiasis (CP) or microfilaraemia (MF). The percentage of positive
lymphocytes from each patient, determined by comparison of fluores-
cence of specifically labelled cells with that of unlabelled cells for each
sample, is indicated by open (MF) or closed (CP) symbols. The mean
percentage ± 2 s.d. of the 15 normal controls is defined by the shaded
area.
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Table 3. Lymphocyte proliferative response to mitogens
in patients and normal controls
CP NL
(n=9) (n=12)
Mitogen SI* SI SI
PHA 50.12† 68.12 58.28
(39.2-73.2) (22.2-140.5) (44.5-92.5)
ConA 46.67 48.89 39.32
(27.5-79.2) (27.2-93.3) (21.0-85.4)
PWM 18.39 34.38 33.1
(3.2-59.2) (20.1-68.2) (17.26-73.6)
*Stimulation index:
ct/min in mitogen-stimulated culture
ct/min in medium control
† Geometric mean (95% confidence value).
Table 4. Correlation between CD8 + HLA-DR + lym-
phocytes and PWM responses in patients with elephan-
tiasis
CD8+ HLA-DR+ PWM*
Patients (% positive) (stimulation index)
1 8.93 85.62
2 9.37 10.26
3 11.42 29.17
4 12.06 53.00
5 12.19 32.41
6 13.05 80.17
7 15.46 51.07
8 28.94 11.79
9 32.75 10.90
*Spearman rank correlation coefficient = –0.54;
P <001.
Distribution of IL-2R on T lymphocytes
Because IL-2R (CD25) can also be a marker of lymphocyte
activation. its expression on T lymphocyte subpopulations was
analysed but not found on either CD4 or CD8 positive
lymphocytes (data not shown).
Lymphocyte function
The functional capacity of peripheral blood lymphocytes of the
three study groups was next assessed by examining lymphocyte
responses to T cell mitogens (PHA, ConA) and the T cell-
dependent B lymphocyte mitogen (PWM) (Table 3). As seen, all
groups responded equally well to PHA and ConA, whereas
there was a slight (statistically not significant) diminution of the
PWM-induced responses in those with MF compared to
patients with CP or to normals.
Correlation between HLA-DR+ T cells and lymphocyte function
To begin to examine the implications of the increased expression
of HLA-DR on CD8+ lymphocytes, correlations between
expression of this antigen and in vitro lymphocyte responsive-
ness were examined. There was no correlation between HLA-
DR expression on T lymphocytes and in vitro responses to PHA
or ConA, but there was an inverse relation between the
percentage of CD8+ DR+ lymphocytes and the PWM response
(Table 4) in patients with CP (r= –0.54; P <0.001). The
percentage of CD4+ DR+ lymphocytes did not correlate with
the response to any of the three mitogens. In MF patients, there
was no correlation between DR expression and mitogen
responsiveness.
DISCUSSION
Patients with Bancroftian filariasis show a wide spectrum of
immunological and clinical characteristics, often related to their
degrees of immunological responsiveness (Ottesen, 1980). To
understand the mechanisms underlying these immunological
differences, we have examined the relationship between lympho-
cyte subsets and their states of activation by dual-colour flow
cytometry and concurrent in vitro cell culture. The percentages
of total B lymphocytes (CD19), T lymphocytes (CD3), helper/
inducer T lymphocytes (CD4), and suppressor/cytotoxic T
lymphocytes (CD8) in patients with either CP or MF were all 
within the ranges defined by clinically normal individuals taken
from the same population. These results contrast with those of a
previous report of patients with lymphatic filariasis caused by B.
malayi, where increased numbers of CD8-positive T lympho-
cytes were observed in MF individuals (Piessens et al., 1982).
The reasons for this discrepancy are not certain; possibly, it
could relate to differences in filarial species in the study
populations (subperiodic Brugian filariasis in the earlier report
and periodic Bancroftian filariasis in the present one) or to
technical factors (indirect immunofluorescence with manual
counting of cells in the earlier study and flow cytometry analysis
in the present one).
Specific hyporesponsiveness of T cells to filarial parasite
antigens, manifested by minimal antigen-driven T cell prolifer-
ation in vitro despite normal responses to mitogens and non-
parasite antigen (Ottesen et al., 1977; Piessens et al., 1980a;
Nutman et al., 1987a), is well documented in the asymptomatic
group of patients with IMF. Serum suppressor factors (Piessens
et al., 1980b), suppressor adherent cells (Piessens et al., 1980b),
and T suppressor cells (Piessens et al., 1982) have all been
implicated as causes of this parasite-specific immunosuppres-
sion. Our observations here of normal levels of CD4 and CD8
cells and lack of increased expression of activation markers on
either T-cell subset of these MF patients point to a more
complex immunoregulatory network than merely CD4/CD8
interactions and, in agreement with recent reports (Nutman et
al., 1987 a,b), continue to support the concept of ‘acquired
tolerance’ to parasite antigen rather than one implicating global
suppressor cell mechanisms (Piessens et al., 1980b, 1982).
The mechanisms involved in the activation of peripheral
blood lymphocytes following exposure to specific antigens or
mitogens are complex. It has been shown clearly that certain cell
surface determinants expressed only in low proportions or not
at all on resting T cells are-expressed on activated T cells
(Uchiyama et al., 1981 : Ko et al., 1979). Among these ‘T-cell
activation antigens’, the HLA-DR antigen, expressed primarily
on B lymphocytes and monocytes (Winchester et al., 1975) can
be found in a significant proportion of T cells upon activation
(Reinherz et al., 1979; Ko et al., 1979). Another marker, the IL-
2R, is similarly inducible on human T cells activated by
mitogens, soluble antigens, or allo-antigens (Uchiyama et al.,
1981). It has been postulated that these antigens may be part of
the network through which cell-cell signals are conveyed.
The significant increase in circulating T cells bearing the
HLA-BR antigen indicates the presence of activated T cells in
patients with chronic lymphatic pathology. Although the exact
origin and significance of these HLA-DR+ T cells remain to be
determined, it is possible that these cells reflect direct activation
by parasite products and. thus, may be intimately involved in
the pathogenesis of lymphatic obstruction. Alternatively, these
cells may be activated by host mediators released during the
process of the inflammation that clearly accompanies this
particular clinical manifestation of filariasis. Such mechanisms
have been invoked to explain the increased levels of circulating
HLA-DR+ T ceils in several non-parasitic immunologically-
mediated diseases (Yu et al., 1980).
It is possible that these activated T cells in the chronic form
of filariasis are responsible for suppressing the actions of other T
cell subsets or B cells, as most of the HLA-DR+ T cells in these
patients were found on the suppressor/cytotoxic cells (CD8) and
not on the helper/inducer cells (CD4). The regulatory interac-
tions between CD8+ HLA-DR+ cells and other 7 and non-T
cells are still poorly characterized. and further distinction
between the subsets of CD8 cells using Leu-15 (Landay,
Gartland & Clement. 1983) or anti-9.3 (Damle et al., 1983)
should provide additional clues about potential functional roles
these cells might have in filariasis.
Though a population of CD8+ cells was found that
expressed one activation marker (HLA-DR) in patients with
CP, these same cells did not show any enhanced expression of
another activation marker (IL-2R) on their surfaces. While IL-
2R+ CD8 lymphocytes have been described both in vivo and in
vitro, previous studies have indicated that the expression of the
antigen on circulating T cells is likely to be a transient
phenomenon even after antigenic challenge (Yachie et al., 1983).
In an effort to study the functional implications of the HLA-
DR+ T cells in the patients with CP, we related its expression to
mitogen stimulation. There was no correlation between the
expression of HLA-DR on T cells and either the PHA or ConA
responses, but there was an inverse correlation between the
PWM responsiveness and HLA-DR+ CD8+ T cells in these
patients. There are several possible mechanisms that might
account for this pattern of reactivity:
Both PHA and ConA are known to activate T cells through
the CD3 or CD2 pathways (Fleisher, 1984; Valentine et al.,
1985). Since response to both PHA and ConA was intact in
patients with CP, it suggests that CD8+ DR+ lymphocytes
do not exert their effect on these pathways of T cell
activation.
PWM, on the other hand, has been shown to activate T cells
through an alternative IL-2 independent pathway (Ceuppens
et al., 1986), in addition to the classical CD3 pathways (Puck
& Rich, 1984). While CD3 pathways of T cell activation
appear to be unaffected (based on the PHA/ConA data), it is
possible that CD8+ DR+ lymphocytes exert an effect on the
PWM-induced alternate pathway of activation.
Furthermore, PWM-induced proliferation of T cells appears
to be regulated at two levels-one in which CD4 cells
respond directly to PWM thereby producing factors that
drive CD8 cellular proliferation, and another in which
PWM-activated CD8+ cells suppress proliferation by CD4+
cells (Puck & Rich, 1984; Yachie et al., 1982). CD8+ DR+
lymphocytes in elephantiasis may indeed be involved in such
a feedback suppression mechanism.
Our results support the concept that T cell mediated immune
reactions arc operative in patients with the chronic lymphatic
obstructive form of filariasis and are different from those in
patients with asymptomatic microfilaraemia. This difference is
reflected by increased number ofactivated T lymphocytes in the
peripheral blood. Whether these activated T cells function
favourably or unfavourably for the host, however, remains to be
determined.
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